However, in squamous cell lung cancer, the incidence of epidermal growth factor receptor (EGFR) gene mutant and ALK fusion gene are low, and targeted therapy like Tarceva and crizotinib, can hardly work. Here, EGFR is linked to squamous cell lung carcinoma.